Neurogenetics Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892, USA.
Mol Biol Cell. 2013 Jun;24(12):1863-71. doi: 10.1091/mbc.E13-01-0042. Epub 2013 Apr 24.
Spinal muscular atrophy is an inherited motor neuron disease that results from a deficiency of the survival of motor neuron (SMN) protein. SMN is ubiquitinated and degraded through the ubiquitin proteasome system (UPS). We have previously shown that proteasome inhibition increases SMN protein levels, improves motor function, and reduces spinal cord, muscle, and neuromuscular junction pathology of spinal muscular atrophy (SMA) mice. Specific targets in the UPS may be more efficacious and less toxic. In this study, we show that the E3 ubiquitin ligase, mind bomb 1 (Mib1), interacts with and ubiquitinates SMN and facilitates its degradation. Knocking down Mib1 levels increases SMN protein levels in cultured cells. Also, knocking down the Mib1 orthologue improves neuromuscular function in Caenorhabditis elegans deficient in SMN. These findings demonstrate that Mib1 ubiquitinates and catalyzes the degradation of SMN, and thus represents a novel therapeutic target for SMA.
脊髓性肌萎缩症是一种遗传性运动神经元疾病,由运动神经元存活(SMN)蛋白缺乏引起。SMN 通过泛素蛋白酶体系统(UPS)被泛素化和降解。我们之前已经表明,蛋白酶体抑制可增加 SMN 蛋白水平,改善运动功能,并减少脊髓性肌萎缩症(SMA)小鼠的脊髓、肌肉和神经肌肉接头病理学。UPS 中的特定靶标可能更有效且毒性更小。在这项研究中,我们表明 E3 泛素连接酶,mind bomb 1(Mib1)与 SMN 相互作用并泛素化 SMN,促进其降解。敲低 Mib1 水平可增加培养细胞中的 SMN 蛋白水平。此外,敲低 Mib1 同源物可改善缺乏 SMN 的秀丽隐杆线虫的神经肌肉功能。这些发现表明 Mib1 泛素化并催化 SMN 的降解,因此代表了 SMA 的一种新的治疗靶点。